Teva Pharmaceutical Industries Ltd.

URI: https://gptkb.org/entity/Teva_Pharmaceutical_Industries_Ltd.
GPTKB entity
Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Actavis_Generics
gptkbp:acquisitionYear 2016
gptkbp:CEO gptkb:Richard_Francis
gptkbp:competitor gptkb:Pfizer
gptkb:Sandoz
gptkb:Novartis
gptkb:Mylan
gptkbp:country gptkb:Israel
gptkbp:division gptkb:Over-the-Counter_(OTC)_Products
Generic Medicines
Specialty Medicines
gptkbp:foundedIn gptkb:Israel
gptkbp:foundedYear 1901
gptkbp:founder gptkb:Chaim_Salomon
gptkb:Moshe_Levin
gptkb:Yitschak_Elstein
gptkbp:headquartersLocation gptkb:Petah_Tikva,_Israel
https://www.w3.org/2000/01/rdf-schema#label Teva Pharmaceutical Industries Ltd.
gptkbp:industry Pharmaceuticals
gptkbp:ISIN IL0006290147
gptkbp:legalForm gptkb:public_company
gptkbp:listedOn gptkb:Forbes_Global_2000
gptkbp:logo Teva_logo.svg
gptkbp:market Global
gptkbp:marketCap ~$12 billion (2024)
gptkbp:memberOf gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
gptkbp:notableCase Generic drug price-fixing investigations
Opioid crisis lawsuits
gptkbp:notableEvent Opioid litigation settlements
gptkbp:notableProduct gptkb:Ajovy
gptkb:Austedo
gptkb:Copaxone
gptkbp:numberOfEmployees 2023
~37,000
gptkbp:parentCompany gptkb:Teva_Group
gptkbp:products Over-the-counter drugs
Generic drugs
Specialty medicines
gptkbp:revenue $15.8 billion (2023)
gptkbp:servesArea Worldwide
gptkbp:stockExchange gptkb:TASE
gptkb:NYSE
gptkbp:stockSymbol gptkb:TEVA
gptkbp:subsidiary gptkb:Cephalon
gptkb:Teva_Neuroscience
gptkb:Teva_API
gptkbp:website https://www.tevapharm.com/
gptkbp:bfsParent gptkb:TEVA
gptkbp:bfsLayer 6